Strength Training and Prevention of Sarcopenia
Not Applicable
Completed
- Conditions
- Sarcopenia.Muscle wasting and atrophy, not elsewhere classified
- Registration Number
- IRCT201111121058N2
- Lead Sponsor
- Research Institute for Endocrine Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Inclusion Criteria: post menopausal woman; age over 50 years old.
Exclusion Criteria
taking hormone replacement therapy (HRT); use of medications like ß-adrenergic blockers, ß-agonists, Ca2+ channel blockers and corticosteroids; having diabetes, Parkinson’s disease and peripheral neuropathy.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Muscle Weakness. Timepoint: ?At baseline, After 12 weeks, After 16 weeks. Method of measurement: Caliper.
- Secondary Outcome Measures
Name Time Method Rang of Motion. Timepoint: At baseline, After 12 weeks, After 16 weeks. Method of measurement: Sit and Reach.